Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Operations

v3.19.1
Consolidated Statements of Operations - USD ($)
 12 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Revenue:    
Total revenue $ 2,457,871 $ 2,240,498
Costs and expenses:    
Cost of products and services 1,280,270 1,273,354
Research and development 1,208,160 988,597
Selling and marketing 1,009,568 1,209,334
General and administrative 3,436,956 3,416,261
Total operating costs and expenses 6,934,954 6,887,546
Operating loss (4,477,083) (4,647,048)
Other (expense) income:    
Interest expense (4,168,214) (6,055,420)
Other expense (15,135) (5,674)
Impairment loss on investment (6,069)
Gain on extinguishment of liabilities 260,454 185,452
Incentive shares and warrants (1,299,340) (186,802)
Change in fair value of derivative liabilities
Total other (expense) income (5,222,235) (6,068,513)
Net loss (9,699,318) (10,715,561)
Deemed dividends on down round feature     (213,012)
Deemed dividends on beneficial conversion feature (12,881,899)
Preferred stock dividends (678,921)
  Net loss attributable to common shareholders $ (23,473,150) $ (10,715,561)
Net loss per share - basic and diluted $ (15.33) $ (9.62)
Weighted average common stock shares outstanding used in the basic and diluted net loss per share calculation 1,530,989 1,114,225
Products, Services, Other [Member]    
Revenue:    
Total revenue $ 2,200,539 $ 2,065,891
Grant Revenue [Member]    
Revenue:    
Total revenue $ 257,332 $ 174,607